Page 36 - MemoriaCIBER-2017ENG

NANBIOSIS ICTS Platform
Coordinator: Jaume Veciana Miró
In 2017 the internal evaluation protocol of the units was updated to assign economic incentives, adap-
ting the parameters stipulated by the MINECO for evaluating ICTS
The NANBIOSIS was presented at international bodies, national companies, private research founda- tions and public research bodies, as well as at many national and international events These included the Annual Conference of Platforms for Research into Biomedicine, where NANBIOSIS was presented in the main programme, ETPN2017, as well as through its participation in the MATERPLAT Platform, at which the NANBIOSIS Coordinator is co-leader of the Group for Innovation in Health and partnering events for seeking associates such as BioEurope (Berlin) NANBIOSIS was invited to present its activity at the annual session of the thematic areas of CIBERES, CIBEREHD, CIBERESP, CIBERSAM, CIBERDEM, or at the meeting of the Lung Cancer Group of the CIBERONC There was also a second meeting of the Advisory Scienti c Meeting of NANBIOSIS to discuss the strategic plan for infrastructure, which was held coinciding with the annual sessions of CIBER-BBN
Similarly, the relation with EATRIS was promoted, establishing joint lines of action In fact, the repre- sentatives of NANBIOSIS were invited to attend the “Enhancing Predictivity in Medicines Development” Translational Medicine Conference forum in Prague in September 2017, where they had a meeting with the EATRIS management
The search for external nancing from both public and private sources was a priority The renovation of NANBIOSIS was requested as ITCS to the MINECO, currently in the evaluation stage The collabora- tive schemes already started with companies were also followed up Some examples are the projects entitled TERET, BIOTAPES and “Development of bioprinting and biotint systems for three-dimensional regeneration of cartilage and bone”, all in the CHALLENGE-COLLABORATION programme, the European BERENICE project (FP7), the DRIVE project (H2020), or the PRONANBIOSIS project which allows, amongst others, the integration of NANBIOSIS and the improvement in its management Several activities have been carried out such as the execution of the marketing plan, getting under way online promotion and activation of its presence on social networks A new person also joined the programme to be able to carry out ICTS management tasks, such as for example the processing of almost 300 applications for access
In an attempt to promote cooperation with companies, the design of an integrated service for Nanome- dicine Cascade Characterisation, including the services required to characterise their physical-chemical attributes, their in vitro and in vivo biological properties (immunology, toxicology and e ciency), using appropriate animal models as knowledge basis to accelerate the ISCIII Transfer of research into nano- materials and nanodevices to clinical practice For the time being the units involved have been identi ed and meetings have been held with the parties responsible for determining the tests to be performed, the complementary services and the coordinators and interlocutors for each of the stages in the cha- racterisation
As well as maintaining cooperation with other infrastructures, the rst actions with EATRIS have been designed for establishing long-term collaboration
36 CIBER ANNUAL REPORT 2017